Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Medulloblastoma
100%
Tumor
67%
Genome Analysis
27%
Atypical Teratoid/rhabdoid Tumor
26%
Ependymoma
24%
Pan-cancer Analysis
23%
Sonic Hedgehog
19%
Pediatric
16%
Molecular Subgroups
16%
SMARCB1
16%
DNA Methylation Profiling
14%
Tumor Subtype
13%
Myxopapillary Ependymoma
11%
Sonic Hedgehog Medulloblastoma
11%
Embryonal Tumor with multilayered Rosettes
11%
Brain Tumor
11%
Human Cancer
11%
Medulloblastoma Subgroups
10%
Overall Survival
9%
Progression-free Survival
9%
Molecular Characterization
9%
Pediatric Brain Tumor
9%
Central Nervous System Tumors
9%
Tumorigenesis
8%
Molecular Analysis
8%
Multidrug Resistance Protein
8%
Risk Stratification
8%
TP53 mutation
8%
In Cancer
7%
Overexpression
7%
Genetic Modification
7%
Supratentorial
7%
Multidrug Resistance-associated Protein 2 (MRP2)
7%
Gene Expression
7%
Epigenetics
7%
Cancer Genome
6%
Autographa Californica
6%
Chromothripsis
6%
Whole Genome Sequencing
6%
Group 3 Medulloblastoma
6%
Tumor Entity
6%
Clinical Trials
6%
Rhabdoid Tumor
6%
Childhood Brain Tumors
6%
Multidrug Resistance Protein 1 (MDR1)
6%
Histology
6%
DNA Methylation (DNAm)
6%
Primary Tumor
6%
Chemotherapy
6%
Poor Prognosis
6%
Biochemistry, Genetics and Molecular Biology
Pediatrics
33%
Genomics
22%
DNA Methylation
19%
Sonic Hedgehog
18%
Carcinogenesis
17%
SMARCB1
17%
Genetics
13%
Methylation
12%
Transcriptome
12%
Pan-cancer
11%
Gene Expression Profiling
11%
Gene Expression
11%
Messenger RNA
10%
Whole Genome Sequencing
10%
Clinical Trial
9%
RNA Sequence
8%
MicroRNA
8%
Oncogene
7%
Gene Mutation
7%
Promoter Region
7%
Overall Survival
7%
Chromatin
6%
Germ Cell
6%
Chromothripsis
5%
Germline
5%
Progression Free Survival
5%
Hedgehog Signaling Pathway
5%
Transcription Factors
5%
Cytogenetics
5%
Targeted Therapy
5%
Transcriptomics
5%
Tumor Suppressor Protein
5%
Medicine and Dentistry
Medulloblastoma
44%
Tumor
37%
Pediatrics
21%
Malignant Neoplasm
17%
Neoplasm
14%
Ependymoma
12%
Atypical Teratoid Rhabdoid Tumor
12%
Genetics
11%
Sonic Hedgehog Protein
9%
Cancer
9%
Overall Survival
9%
DNA Methylation
8%
Progression Free Survival
7%
Intracranial Tumor
7%
Chemotherapy
7%
Radiation Therapy
7%
Ganglioglioma
7%
Diseases
6%
Biological Marker
6%
Risk Stratification
6%
Central Nervous System Tumor
6%
Rosette Formation
6%
Clinical Trial
5%
Somatics
5%
Posterior Fossa
5%
